ct, Inc., a
wholly owned subsidiary of Financial Media Group, Inc.
(
http://www.financialmediagroupinc.com). The Web site is a leading provider
of timely business news, executive interviews, multimedia content, and
research tools. Financial Media Group, Inc. also owns
http://www.mywallst.net, a financial social network for investors, and
Financial Filings Corp. (
http://www.financialfilings.com), a provider of
media and compliance solutions to publicly traded companies. In addition to
WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio
(
http://www.wallstradio.com), a business and finance podcast Web site.
Financial Filings Corp. has received two hundred eighty dollars from
RegeneRx Biopharmaceuticals, Inc. as reimbursement for the dissemination of
this press release. For a complete list of our advertisers, and advertising
relationships, visit
http://www.wallst.net/disclaimer/disclaimer.asp.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)
Contact: WallSt.net
800-4-WALLST
'/>"/>SOURCE Financial Filings Corp.
 Copyright©2007 PR Newswire. | |
Page: 1 2 Related medicine technology :1.
Pro-Pharmaceuticals Updates Progress of Clinical Trials &
Davanat 505 (b)(2) Filings2.
Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial3.
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing
Sustained Safety and Significant Reductions in Repeat Procedures4.
NCCN Updates Esophageal and Gastric Cancer Guidelines5.
Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS
301012 in Familial Hypercholesterolemia Patients6.
Tercica to Present at Investment Conferences7.
July Issue of Journal of Antimicrobial Chemotherapy Highlights
Study of Factive Tablets for Five-Day Treatment of
Community-Acquired Pneumonia8.
BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease9.
BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease10.
Trial Results with Intranasal Fentanyl Hold Promise for Treatment
of Breakthrough Pain in Cancer11.
Hemispherx Presents Potential Avian Influenza Treatment
Breakthrough at Paris Conference